Exagen Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

Albuquerque, NM and San Diego, CA, Oct. 30, 2018 – — Exagen Diagnostics, a leader in autoimmune life sciences, today announced that President and Chief Executive Officer, Ron Rocca, will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum to be held in New York, NY at the Westin Grand Central Hotel on Thursday, November 15, 2018 at 11:30 a.m. Eastern Time. Mr. Rocca will present an overview of the patented cell-bound complement activation products (CB-CAPs) technology and other recent advances for the AVISE®  brand of testing.Kamal Adawi
Exagen Diagnostics, Inc.
760.477.5514
IR@exagen.com

Leave a Reply

Your email address will not be published. Required fields are marked *